RE:Various questions and observations from a newbieHI Tundup, nice post thank you
As to your questions;
1)Covered
2)Yes share count is about 100m as you and GV have stated. One thing though is that the royalty is due Zenith on proceeds from commercialization.
3)JK gave you the history of the relationship between DM and Norman Wong. Norman Wong has a lengthy track record of scientific achievement and IMO this is what attracted the world class science team to RVX and his novel ideas in the HDL space.
4)Again my opinion, but I'm not sure that there has been no interest from larger players I just think between NGN and Eastern there is no more room. One could never say for sure, but I think that Arthur Higgins presence in RVX's boardroom evidenced this and that likely part of the reason he left was there was no room financially for Blackstone.
5)Hard to figure why AZ isn't looking at RVX as at the very least an insurance policy and a way to extend patent life on Rosuvastatin. I think this is probably tempered by the fact that RVX, Eastern and NGN probably would want a very rich deal to sell "early". I think RVX is quite confident in their program and every bit of information they release would seem to support this confidence.